UPDATE 2-Abbott beats Street on strong medical device, generics sales
October 18, 2017 at 09:29 AM EDT
Oct 18 (Reuters) - Abbott Laboratories' profit and sales topped analysts' estimates on robust sales of medical devices and generic drugs, leading it to raise the high-end of its adjusted earnings forecast for the year.
